Your browser doesn't support javascript.
loading
D-Dimer Levels and Effect of Rivaroxaban on Those Levels and Outcomes in Patients With Acute Coronary Syndrome (An ATLAS ACS-TIMI 46 Trial Substudy).
AlKhalfan, Fahad; Kerneis, Mathieu; Nafee, Tarek; Yee, Megan K; Chi, Gerald; Plotnikov, Alexei; Braunwald, Eugene; Gibson, C Michael.
Afiliación
  • AlKhalfan F; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Kerneis M; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Nafee T; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Yee MK; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Chi G; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts.
  • Plotnikov A; Johnson & Johnson Pharmaceutical Research and Development, Raritan, New Jersey.
  • Braunwald E; Division of Cardiovascular Medicine, TIMI Study Group, Brigham and Women's Hospital, Harvard Medical School, Boston, Massachusetts.
  • Gibson CM; Division of Cardiovascular Medicine, The PERFUSE Study Group, Beth Israel Deaconess Medical Center, Harvard Medical School, Boston, Massachusetts. Electronic address: mgibson@perfuse.org.
Am J Cardiol ; 122(9): 1459-1464, 2018 11 01.
Article en En | MEDLINE | ID: mdl-30217378
Asunto(s)
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Productos de Degradación de Fibrina-Fibrinógeno / Síndrome Coronario Agudo / Inhibidores del Factor Xa / Rivaroxabán Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2018 Tipo del documento: Article
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Bases de datos: MEDLINE Asunto principal: Productos de Degradación de Fibrina-Fibrinógeno / Síndrome Coronario Agudo / Inhibidores del Factor Xa / Rivaroxabán Tipo de estudio: Clinical_trials / Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male / Middle aged Idioma: En Revista: Am J Cardiol Año: 2018 Tipo del documento: Article